T2 Biosystems's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; T2 Biosystems is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-2.27. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.47M	$ 1.96M	$ 2.08M	$ 5.48M	$ 3.68M
Gross Profit	$ -2.45M	$ -2.90M	$ -1.92M	$ 1.75M	$ -2.41M
EBIT	$ -14.31M	$ -4.81M	$ -16.44M	$ -7.75M	$ -15.81M
EBITDA	$ -13.70M	-	$ -15.82M	$ -7.23M	$ -15.24M
Net Income Common Stockholders	$ -15.43M	$ -6.35M	$ -17.96M	$ -10.10M	$ -17.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 24.30M	$ 16.10M	$ 10.12M	$ 10.33M	$ 20.37M
Total Assets	$ 43.28M	$ 37.13M	$ 32.73M	$ 34.33M	$ 43.95M
Total Debt	$ 49.48M	$ 59.48M	$ 59.35M	$ 59.22M	$ 59.05M
Net Debt	$ 25.18M	$ 43.38M	$ 49.24M	$ 48.89M	$ 38.69M
Total Liabilities	$ 62.52M	$ 73.55M	$ 82.62M	$ 73.98M	$ 75.62M
Stockholders Equity	$ -19.20M	$ -36.40M	$ -49.90M	$ -39.70M	$ -31.67M
Cash Flow	-
Free Cash Flow	$ -13.41M	-	$ -13.02M	$ -10.37M	$ -16.03M
Operating Cash Flow	$ -13.39M	$ -12.39M	$ -12.90M	$ -10.33M	$ -15.90M
Investing Cash Flow	$ -13.00K	$ -33.00K	$ -120.00K	$ -36.00K	$ -126.00K
Financing Cash Flow	$ 21.64M	$ 18.39M	$ 11.85M	$ 748.00K	$ 23.18M

Currency in USD

T2 Biosystems Earnings and Revenue History

Income Statement >

T2 Biosystems Debt to Assets

Balance Sheet >

T2 Biosystems Cash Flow

Cash Flow >

T2 Biosystems Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing